---
title: Hongene Biotech Corporation vs Sophia CDMO
slug_a: hongene
slug_b: sophiacdmo
site: cdmo
review_signal_gate: closed
canonical_path: /compare/hongene/sophiacdmo
generated_by: BioBM Editorial AI
---

# Hongene Biotech Corporation vs Sophia CDMO

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Hongene Biotech Corporation (hongene) is listed for cdmo. Hongene is a vertically-integrated CDMO offering end-to-end oligonucleotide and mRNA manufacturing from raw materials to GMP drug product, with nearly 30 years of RNA-focused expertise and tonne-scale production capacity.

Services: 12. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (12).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sophia CDMO (sophiacdmo) is listed for cdmo. European CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.

Services: 18. Modalities: 5. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (18).

Review summary: Review summary withheld until site-level review gate opens.